Skip to main navigation Skip to search Skip to main content

Bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy

  • Yanan Zhao
  • , Ting Li
  • , Yao Yao
  • , Shujuan Xue
  • , Tao Xu
  • , Shuqi Mi
  • , Dazhao Li
  • , Xiaolei Tang
  • , Feng Zhi
  • , Dawei Ding*
  • , Huabing Chen*
  • *Corresponding author for this work
  • Soochow University
  • Xuzhou Medical University
  • Royal College of Surgeons in Ireland
  • The Third Affiliated Hospital of Soochow University
  • Ltd.
  • Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases
  • The First Affiliated Hospital of Soochow University

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Reactive oxygen species (ROS)-based antitumor compounds show great promise in cancer treatments such as chemodynamic therapy (CDT) and photodynamic therapy (PDT), but are severely restricted by both endogenous antioxidants and hydrogen peroxide (H2O2). Here, we synthesize bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide (CuO2) nanoparticles for CDT/PDT-synergized immunotherapy against aggressive triple-negative breast cancers (TNBCs). The CuO2 nanoparticles are established to afford pH-responsive decomposition into H2O2 and Cu2+, followed by the reduction into Cu+ by glutathione and subsequent catalysis reaction of H2O2 into highly reactive ·OH, thus yielding CDT-mediated cell injury. Meanwhile, the glutathione consumption from the nanoparticles attenuates their ROS scavenging to promote singlet oxygen generation of co-assembled indocyanine green upon light exposure, thereby amplifying PDT-based cell damage. Moreover, the dully enhanced CDT/PDT damages of the nanoparticles provoke potent immunogenic cell death that further synergizes with immune checkpoint inhibitor via relieving indoleamine 2,3-dioxygenase 1-mediated immunosuppression, thus amplifying immunotherapeutic efficacy against primary, distant and metastatic TNBCs. This work provides valuable insights into nanomedicines for synergistic cancer therapy.

Original languageEnglish
Article number123988
JournalBiomaterials
Volume329
DOIs
Publication statusPublished - Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chemodynamic therapy
  • Immune checkpoint blockade
  • Nanoparticles
  • Photodynamic therapy
  • Reactive oxygen species

Cite this